Metabolic syndrome: Evaluation of pathological and therapeutic outcomes

This publication has 91 references indexed in Scilit:

• Metabolic syndrome: Definition, pathophysiology, and mechanisms
  American Heart Journal, 2005
• Inflammation in atherosclerosis
  Nature, 2002
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Leptin-Replacement Therapy for Lipodystrophy
  New England Journal of Medicine, 2002
• Metabolic and Additional Vascular Effects of Thiazolidinediones
  Drugs, 2002
• Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis
  The Lancet, 2001
• Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations11The views contained herein represent the private views of the authors and should not be construed in any way to represent those of the Department of Defense or the Department of the Army.
  The American Journal of Cardiology, 2000
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
  The Lancet, 1998
• The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐up
  Journal of Internal Medicine, 1994
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987